Skip to main content
Log in

Determination of Buprenorphine and Naloxone in Patient Blood Plasma Using HPLC-MS

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

A method for determining buprenorphine and naloxone in human plasma using liquid chromatography and high-resolution time-of-flight mass spectrometry (LC-MS Q-TOF) was developed. The sample preparation technique included liquid extraction with salting out of the analytes in Toxi-Tubes Aintended for the determination of neutral and basic compounds. Quantitative analysis was carried out by the internal standard method. Naltrexone, which was structurally similar to the analytes, was used as the internal standard. The proposed method was developed for clinical trials of the new drug bupraxone, a sublingual dosage form containing buprenorphine and naloxone at doses of 0.2 mg each. The bioavailability of the drug components upon sublingual administration was studied. The buprenorphine concentrations in human plasma after administration at a dose of 0.4 mg via two routes (intravenous and sublingual) were compared.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. http: // ru.wikipeida.org/wiki/%D0%91%D1%83%D0%BF%D1%80%D0%B5%D0%BD%D0%BE%D1%80%D1%8 4%D0%B8%D0%BD

  2. http: // www.russlav.ru/narkotik/byprenorfin.html

  3. F. Tagliaro, D. Franchi, R. Dorizzi, et al., J. Chromatogr., 488(1), 215 – 228 (1989).

    Article  CAS  PubMed  Google Scholar 

  4. R. F. Venn and A. Michalkievicz, J. Chromatogr., 525(2), 379 – 388 (1990).

    Article  CAS  PubMed  Google Scholar 

  5. G. Chari, A. Gulati, R. Bhat, et al., J. Chromatogr., 571(1 – 2), 263 – 272 (1991).

    Article  CAS  PubMed  Google Scholar 

  6. R. S. Schwartz and K. O. David, Anal. Chem., 57(7), 1362 – 1366 (1985).

    Article  CAS  Google Scholar 

  7. K. R. Bedford and P. C. White, J. Chromatogr., 347(3), 398 – 404 (1985).

    Article  CAS  PubMed  Google Scholar 

  8. J. G. Besner, C. Band, J. J. Rondeau, et al., J. Pharm. Biomed. Anal., 7(12), 1811 – 1817 (1989).

    Article  CAS  PubMed  Google Scholar 

  9. P. O. Edlund, J. Chromatogr., 206, 109 – 116 (1981).

    Article  CAS  PubMed  Google Scholar 

  10. R. A. Tasker and K. Nakatsu, Analyst, 111(5), 563 – 565 (1986).

    Article  CAS  PubMed  Google Scholar 

  11. D. French, A. Wu, and K. Lynch, Bioanalysis, 3(23), 2603 – 2612 (2011).

    Article  CAS  PubMed  Google Scholar 

  12. L. Couchman and P. E. Morgan, Biomed. Chromatogr., 25(1 – 2), 100 – 123 (2011).

    Article  CAS  PubMed  Google Scholar 

  13. H. H. Maurer, Anal. Bioanal. Chem., 388(7), 1315 – 1325 (2007).

    Article  CAS  PubMed  Google Scholar 

  14. IUPAC Nomenclature Rules for Chemistry [in Russian], Vol. 1, Half-vol. 2, Moscow (1979), pp. 553 – 561.

  15. ASEAN Guidelines for Validation of Analytical Procedures (2003).

  16. U. P. Shah, K. K. Medha, S. V. Dighe, et al., J. Pharm. Sci., 81(3), 309 – 312 (1992).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 48, No. 10, pp. 51 – 56, October, 2014.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhurkovich, I.K., Rudenko, A.O., Chelovechkova, V.V. et al. Determination of Buprenorphine and Naloxone in Patient Blood Plasma Using HPLC-MS. Pharm Chem J 48, 690–695 (2015). https://doi.org/10.1007/s11094-015-1161-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-015-1161-8

Keywords

Navigation